VibroCell

VibroCell is a vibrational harmonic resonant energy device and cell therapy platform developed by Leonhardt Ventures for cardiovascular applications. The system is designed to prevent the formation of blood clots, plaque, and calcification within the heart, aorta, heart valves, and arteries. It functions by scanning internal blood contact devices and organs for high-risk stagnation points and delivering targeted vibrational acoustic energy until harmonic resonance is reached, thereby maintaining vessel patency and preventing stagnation-related complications. The device is administered via an external elastic belt that wraps around the patient's torso and communicates with a smartphone application to optimize positioning. VibroCell is part of a suite of regenerative technologies that combine bioelectronic stimulation with cell therapy to treat chronic cardiovascular conditions.

Brand names

VibroCell

Other names

CoroStim